| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.3 | 0.05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.35 | 0.06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |